ARTMS seeks FDA nod to produce gallium-68

By staff writers

March 31, 2021 -- ARTMS has submitted a drug master file to the U.S. Food and Drug Administration (FDA) for multicurie production of the radioisotope gallium-68 using the company's technology and medical cyclotrons.

ARTMS made the move because the current supply chain for germanium and gallium generators cannot keep up with projected demand. Getting approval from the FDA will help solve supply issues by enabling the company to use its network of cyclotrons to produce the radioisotopes.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking